Impact of Adipose Tissue Repartition on the Time Course of Vascular Dysfunction - the NUMEVOX Cohort

University Hospital, Angers500 enrolled

Overview

The NUMEVOX cohort is intended to follow-up the macro and microvascular dysfunction in relation to adipose tissue repartition in patients with metabolic syndrome associated to liver steatosis, sleep apnea. Duration of the follow-up is 3 years for each patient entering the cohort.

Study Type

OBSERVATIONAL

Enrollment

500

Conditions

Metabolic Diseases Sleep Apnea Atherosclerosis

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * informed consent * age \> 18 years old * suspected of metabolic syndrome * affiliated to french social health care Exclusion Criteria: * age \< 18 years old * pregnancy * no informed consent * not eligible for the study (no MS, cancer)

Locations (1)

Pôle Maladies Métaboliques et Médecine Interne

Angers, France

RECRUITING

Central Contacts

PIERRE HENRI DUCLUZEAU, MD PhD

CONTACT

33(0)663384160 phducluzeau@chu-angers.fr

GEORGES LEFTHERIOTIS, MD-PHD

CONTACT

33(2)41-35-44-56 geleftheriotis@chu-angers.fr

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.